GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » QLY Biotech Group Corp (OTCPK:LQLY) » Definitions » Debt-to-Revenue

QLY Biotech Group (QLY Biotech Group) Debt-to-Revenue : N/A (As of Feb. 2023)


View and export this data going back to 2021. Start your Free Trial

What is QLY Biotech Group Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

QLY Biotech Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2023 was $0.00 Mil. QLY Biotech Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2023 was $0.00 Mil. QLY Biotech Group's annualized Revenue for the quarter that ended in Feb. 2023 was $0.00 Mil.


QLY Biotech Group Debt-to-Revenue Historical Data

The historical data trend for QLY Biotech Group's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QLY Biotech Group Debt-to-Revenue Chart

QLY Biotech Group Annual Data
Trend Aug19 Aug20 Aug21 Aug22
Debt-to-Revenue
N/A 2.00 3.00 N/A

QLY Biotech Group Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of QLY Biotech Group's Debt-to-Revenue

For the Travel Services subindustry, QLY Biotech Group's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QLY Biotech Group's Debt-to-Revenue Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, QLY Biotech Group's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where QLY Biotech Group's Debt-to-Revenue falls into.



QLY Biotech Group Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

QLY Biotech Group's Debt-to-Revenue for the fiscal year that ended in Aug. 2022 is calculated as

QLY Biotech Group's annualized Debt-to-Revenue for the quarter that ended in Feb. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Feb. 2023) Revenue data.


QLY Biotech Group Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of QLY Biotech Group's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


QLY Biotech Group (QLY Biotech Group) Business Description

Traded in Other Exchanges
N/A
Address
5348 Vegas Drive, Las Vegas, NV, USA, 89108
Website
QLY Biotech Group Corp is a United States based company engaged in the tourism business.

QLY Biotech Group (QLY Biotech Group) Headlines

No Headlines